|
| 宣泰医药(688247)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-08-25 | 31101.84 | 68.61% | 45334.00 | 0.00 | 14005.46 | 30.89% | 首发原股东限售股份 | | 2024-08-26 | 226.70 | 0.50% | 14232.16 | 31101.84 | 14181.11 | 31.28% | 首发战略配售股份 | | 2023-08-25 | 9698.16 | 21.39% | 14181.11 | 31152.89 | 4482.95 | 9.89% | 首发原股东限售股份 | | 2023-02-27 | 216.31 | 0.48% | 4482.95 | 40851.05 | 4482.95 | 9.89% | 首发机构配售股份 | | 2022-08-25 | 4090.99 | 9.02% | 4090.99 | 41243.01 | 4090.99 | 9.02% | 首发一般股份 |
|